Novel Amycolatopsis balhimycina biochemical abilities unveiled by proteomics: FEMS Microbiol Lett

R. Alduina, G. Gallo, G. Renzone, Tilmann Weber, A. Scaloni, A. M. Puglia

Research output: Contribution to journalJournal articleResearchpeer-review

118 Downloads (Pure)


Amycolatopsis balhimycina DSM5908 is an actinomycete producer of balhimycin, an analogue of vancomycin, the antibiotic of 'last resort' against multidrug-resistant Gram-positive pathogens. Most knowledge on glycopeptide biosynthetic pathways comes from studies on A. balhimycina as this strain, among glycopeptide producers, is genetically more amenable. The recent availability of its genome sequence allowed to perform differential proteomic analyses elucidating key metabolic pathways leading to antibiotic production in different growth conditions. To implement proteomic data on A. balhimycina derived from 2-DE approaches and to identify novel components, a combined approach based on protein extraction with different detergents, SDS-PAGE resolution of intact proteins and nanoLC-ESI-LIT-MS/MS analysis of their tryptic digests was carried out. With this procedure, 206 additional new proteins such as very basic, hydrophobic or large species were identified. This analysis revealed either components whose expression was previously only inferred by growth conditions, that is, those involved in glutamate metabolism or in resistance, or proteins that allow the strain to metabolize alkanes. These findings will give additional insight into metabolic pathways that could really contribute to A. balhimycina growth and antibiotic production and metabolic enzymes that could be manipulated to generate a model producing strain to use for synthetic biology.
Original languageEnglish
JournalF E M S Microbiology Letters
Pages (from-to)209-215
Publication statusPublished - 2014
Externally publishedYes


  • 1D-electrophoresis actinomycetes glutamate dehydrogenase glycopeptide antibiotics mass spectrometry


Dive into the research topics of 'Novel Amycolatopsis balhimycina biochemical abilities unveiled by proteomics: FEMS Microbiol Lett'. Together they form a unique fingerprint.

Cite this